Evidence map›Paper›PMID 30235654›Full record

SynthesisMedicine2018

The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery: A meta-analysis.

Yunfeng Jiang, Junhong Li, Huasheng Lin, Qiaotong Huang, Tongbiao Wang, Shijie Zhang, Qing Zhang, Zheng Rong, Jun Xiong

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Article
  7. Observational
  8. Rebound Pain After Regional Anaesthesia.Medicina (Kaunas, Lithuania) · 2025
    Review
  9. Review
  10. Article
  11. Gabapentin enhances the antinociceptive effect of intrathecal morphine in refractory cancer pain patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yunfeng JiangOncology Department, The First Affiliated Hospital of Guangxi University of Chinese Medicine Medical Ethics Committee Department of Spleen and Stomach Liver Disease, Nanning, Guangxi College of Education Science, Guangxi Teachers Education University, Nanning Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China.
Junhong Li
Huasheng Lin
Qiaotong Huang
Tongbiao Wang
Shijie Zhang
Qing Zhang
Zheng Rong
Jun Xiong
Guangxi University of Chinese Medicine · CNThe First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine · CNCommittee on Publication Ethics · GBGuangxi Center for Disease Prevention and Control · CNNanning Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of this meta-analysis from randomized controlled trials (RCTs) was to determine the efficacy and safety of the preoperative use of gabapentin for the treatment of acute and chronic postoperative pain following breast cancer surgery.

methodsIn November 2017, a systematic computer-based search was conducted in PubMed, Embase, Web of Science, Cochrane Library, and Google databases. RCTs comparing gabapentin with placebo in patients undergoing breast cancer surgery were retrieved. The primary endpoint was the visual analog scale (VAS) after surgery and 24 hours after surgery and total morphine consumption. The secondary outcomes were incidence of chronic pain and complications (the incidence of nausea). Software Stata 12.0 was used for meta-analysis.

resultsFinally, 9 RCTs were included in the meta-analysis. Results indicated that gabapentin was associated with reduced pain scores after surgery and 24 hours after surgery. Meanwhile, oral gabapentin was associated with a reduction of the total morphine consumption after breast cancer surgery. Similarly, gabapentin was associated with a reduction in the incidence of chronic pain and the incidence of nausea.

conclusionsPreoperative use of gabapentin was able to reduce acute and chronic postoperative pain, total morphine consumption and the occurrence of nausea following breast cancer surgery. Further studies should determine the optimal dose of gabapentin for pain control after breast cancer surgery.

Indexed as

AminesBreast NeoplasmsChronic PainCyclohexanecarboxylic AcidsFemaleGabapentingamma-Aminobutyric AcidHumansMastectomyMorphinePain MeasurementPostoperative PainPreoperative CareRandomized Controlled Trials as TopicAminesCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidMorphine

Identifiers

PMID30235654
PMCPMC6160249
OpenAlexW2895470650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.